Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer’s Disease

作者: Md. Sahab Uddin , Md. Tanvir Kabir , Devesh Tewari , Abdullah Al Mamun , George E. Barreto

DOI: 10.1007/S12035-020-02065-3

关键词:

摘要: Alzheimer’s disease (AD) is a multifactorial and chronic neurodegenerative disorder that interferes with memory, thinking, behavior. The consumption of dietary fat has been considered a vital factor for AD as this related to blood-brain barrier function cholesterol signaling. e4 allele apolipoprotein E (APOE4) primary genetic risk that encodes one many proteins accountable the transport it deemed leading in brain. In case development, causative high level serum/plasma cholesterol. However, statement arguable and, meantime, levels brain individuals are extremely inconstant do not reflect factor. fact, APOE4 neither fundamental nor sufficient advancement AD; just acts synergistic increases danger AD. Another noticeable characteristic area-specific decreases metabolism glucose. It found cells cannot efficiently metabolize fats; hence, they totally rely upon glucose vitality substrate. Thus, suppression can possess an intense effect on actions. Hypometabolism frequently quite recently achieved impressive consideration plausible target interfering progression disease. One promising approach keep up normal supply ketone bodies from ketogenic diet signifies potential therapeutic agent Therefore, review represents role diets combat pathogenesis by considering influence APOE.

参考文章(140)
Miho Ota, Junko Matsuo, Ikki Ishida, Harumasa Takano, Yuma Yokoi, Hiroaki Hori, Sumiko Yoshida, Kinya Ashida, Kentaro Nakamura, Takeshi Takahashi, Hiroshi Kunugi, Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease Neuroscience Letters. ,vol. 690, pp. 232- 236 ,(2019) , 10.1016/J.NEULET.2018.10.048
Andrea Tumminia, Federica Vinciguerra, Miriam Parisi, Lucia Frittitta, Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications International Journal of Molecular Sciences. ,vol. 19, pp. 3306- ,(2018) , 10.3390/IJMS19113306
Md. Sahab Uddin, Abdullah Al Mamun, Zubair Khalid Labu, Oscar Hidalgo‐Lanussa, George E. Barreto, Ghulam Md Ashraf, Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis Journal of Cellular Physiology. ,vol. 234, pp. 8094- 8112 ,(2019) , 10.1002/JCP.27588
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, Md. Jakaria, Bijo Mathew, George E. Barreto, Ghulam Md Ashraf, Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology Molecular Neurobiology. ,vol. 56, pp. 4925- 4944 ,(2019) , 10.1007/S12035-018-1420-2
Siegfried Hoyer, Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Molecular and Chemical Neuropathology. ,vol. 16, pp. 207- 224 ,(1992) , 10.1007/BF03159971
Elizabeta Zaplatic, Muhammed Bule, Syed Zahid Ali Shah, Md. Sahab Uddin, Kamal Niaz, Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease. Life Sciences. ,vol. 224, pp. 109- 119 ,(2019) , 10.1016/J.LFS.2019.03.055
Md. Sahab Uddin, Md. Tanvir Kabir, Md. Jakaria, Abdullah Al Mamun, Kamal Niaz, Md. Shah Amran, George E. Barreto, Ghulam Md Ashraf, Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK Neurotoxicity Research. ,vol. 36, pp. 583- 601 ,(2019) , 10.1007/S12640-019-00047-5
Md Farhad Hossain, Md Sahab Uddin, GM Sala Uddin, Dewan Md Sumsuzzman, Md Siddiqul Islam, George E Barreto, Bijo Mathew, Ghulam Md Ashraf, None, Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology Molecular Neurobiology. ,vol. 56, pp. 8255- 8276 ,(2019) , 10.1007/S12035-019-01660-3
Seetha Harilal, Jobin Jose, Della Grace Thomas Parambi, Rajesh Kumar, Githa Elizabeth Mathew, Md. Sahab Uddin, Hoon Kim, Bijo Mathew, Advancements in nanotherapeutics for Alzheimer's disease: current perspectives. Journal of Pharmacy and Pharmacology. ,vol. 71, pp. 1370- 1383 ,(2019) , 10.1111/JPHP.13132